# Blue Reishi (Ganoderma sinense)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/blue-reishi
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Mushroom/Fungi
**Also Known As:** Ganoderma sinense, Chinese Lingzhi, Black Reishi, Purple Reishi, Dark Reishi, Chinese Reishi

## Overview

Blue Reishi (Ganoderma sinense) is a medicinal mushroom closely related to red reishi, containing bioactive polysaccharides and triterpenoids that drive its primary effects. These compounds modulate [immune function](/ingredients/condition/immune-support), scavenge [free radical](/ingredients/condition/antioxidant)s, and exhibit antitumor activity primarily through beta-glucan-mediated immune pathway activation in preclinical models.

## Health Benefits

• Antitumor activity demonstrated in preclinical studies through polysaccharide compounds (evidence quality: preliminary/preclinical only)
• [Antioxidant](/ingredients/condition/antioxidant) effects shown in basic research studies via radical scavenging mechanisms (evidence quality: preliminary/preclinical only)
• Anticytopenia properties observed in laboratory studies (evidence quality: preliminary/preclinical only)
• Mushroom-poison detoxification effects noted in preclinical research (evidence quality: preliminary/preclinical only)
• [Immunomodulatory](/ingredients/condition/immune-support) support suggested by basic research on polysaccharide components (evidence quality: preliminary/preclinical only)

## Mechanism of Action

Ganoderma sinense polysaccharides, particularly beta-1,3/1,6-glucans, activate macrophages and natural killer cells by binding pattern recognition receptors including Dectin-1 and TLR-2, stimulating downstream NF-κB signaling to upregulate [cytokine](/ingredients/condition/inflammation) production such as TNF-α and IL-6. Triterpenoid compounds including ganoderic acids inhibit topoisomerase activity and suppress HIF-1α-driven tumor angiogenesis in preclinical cancer cell lines. The antioxidant activity is mediated through direct radical scavenging of [reactive oxygen species](/ingredients/condition/antioxidant) and upregulation of endogenous antioxidant enzymes including superoxide dismutase (SOD) and catalase.

## Clinical Summary

The majority of evidence supporting Ganoderma sinense comes from in vitro cell studies and rodent models, with no large-scale randomized controlled trials specifically isolating this species from red reishi (Ganoderma lucidum). Preclinical studies have demonstrated polysaccharide fractions reducing tumor volume in murine xenograft models and showing anticytopenia effects by stimulating bone marrow hematopoiesis in cyclophosphamide-treated mice. Small pilot studies on closely related Ganoderma species suggest immune marker improvements, but these findings cannot be directly extrapolated to Ganoderma sinense without species-specific clinical data. Overall, the evidence base is preliminary and insufficient to support definitive clinical claims in humans.

## Nutritional Profile

Blue Reishi (Ganoderma sinense) contains a nutritional profile broadly similar to other Ganoderma species, though species-specific quantitative data is limited compared to G. lucidum. Macronutrients (per 100g dried fruiting body, estimated): Protein 10–18g (containing all essential amino acids, notably lysine and leucine); Carbohydrates 55–75g (predominantly as complex polysaccharides); Dietary fiber 30–50g (high insoluble fiber content); Fat 1–3g (primarily unsaturated fatty acids including oleic and linoleic acid); Moisture in dried form <13%. Key bioactive compounds: Beta-glucan polysaccharides (estimated 10–50% of dry weight), the primary [immunomodulatory](/ingredients/condition/immune-support) constituents, with backbone structures of β-(1→3) and β-(1→6) glycosidic linkages — bioavailability is low without processing due to rigid cell wall structures; Ganoderic acids (triterpenoids, lanostane-type), estimated 1–3% of dry weight in fruiting bodies, responsible for bitter taste and contributing to antitumor and [antioxidant activity](/ingredients/condition/antioxidant) — G. sinense contains a distinct triterpenoid profile compared to G. lucidum, including ganoderic acid B, C, and G; Adenosine and other nucleosides present in small quantities (<0.1% dry weight); Ergosterol (provitamin D2 precursor), approximately 0.3–0.8% dry weight, converts to vitamin D2 upon UV exposure; Minerals: Potassium (800–1200mg/100g dry), Phosphorus (300–500mg/100g dry), Magnesium (100–200mg/100g dry), Zinc (5–10mg/100g dry), trace amounts of Selenium (variable by substrate, 0.05–0.5mg/100g dry); B-vitamins present in modest amounts including Riboflavin (B2) ~0.4mg/100g dry, Niacin (B3) ~6–8mg/100g dry, Pantothenic acid (B5) trace levels; Melanin pigments (responsible for the characteristic dark coloration of G. sinense, distinguishing it from G. lucidum) present in the outer crust layer — these dark melanin compounds may contribute to its observed antioxidant and radical scavenging properties and are more concentrated in G. sinense than in G. lucidum; Lectins and proteoglycans present in small quantities. Bioavailability notes: Raw or whole dried fruiting body has poor bioavailability of polysaccharides and triterpenoids due to chitin-rich cell walls; hot water extraction significantly improves polysaccharide bioavailability; dual extraction (water + ethanol) is required to solubilize both hydrophilic polysaccharides and lipophilic triterpenoids; spore-derived powder may have higher bioavailability of certain compounds after cell wall cracking processing. Note: Quantitative analytical data specific to G. sinense is sparse in peer-reviewed literature; most values are extrapolated from G. lucidum studies and the limited G. sinense phytochemical characterization available.

## Dosage & Preparation

No clinically studied dosage ranges for Ganoderma sinense have been established in human trials. Standardization methods and optimal forms (extract, powder) lack specific dosing guidelines. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Ganoderma sinense is generally considered well-tolerated in short-term use, with reported side effects including mild gastrointestinal discomfort, dry mouth, and dizziness at higher doses. Due to its immune-modulating properties, it may theoretically interfere with immunosuppressant drugs such as cyclosporine or tacrolimus, and patients with autoimmune conditions should consult a physician before use. Anticoagulant interactions are a concern, as Ganoderma species have demonstrated platelet inhibition in preclinical studies, potentially enhancing the effects of warfarin or aspirin and increasing bleeding risk. Safety data during pregnancy and lactation is insufficient, and use is not recommended in these populations until further research is available.

## Scientific Research

Despite over 2000 years of traditional use, no human clinical trials, RCTs, or meta-analyses specifically studying Ganoderma sinense were identified in the research. All available evidence comes from preclinical or basic research studies focusing on polysaccharide (GSP) components, with reviewers urging the need for clinical trials to validate [immunomodulatory](/ingredients/condition/immune-support) effects in cancer therapy.

## Historical & Cultural Context

Ganoderma sinense has been used in Traditional Chinese Medicine for over 2000 years as a medicinal fungus, primarily for [immunomodulat](/ingredients/condition/immune-support)ion and antitumor support. Though considered inferior to red Reishi (G. lucidum) due to lower polysaccharide content, it has been traditionally used for similar general health promotion purposes.

## Synergistic Combinations

Red Reishi (G. lucidum), Turkey Tail, Cordyceps, Vitamin D3, [Beta-glucan](/ingredients/condition/immune-support)s

## Frequently Asked Questions

### What is the difference between Blue Reishi and Red Reishi?

Blue Reishi (Ganoderma sinense) and Red Reishi (Ganoderma lucidum) are closely related species sharing similar bioactive compound classes including polysaccharides and triterpenoids, but they differ in their specific ganoderic acid profiles and regional prevalence, with Ganoderma sinense being more common in China. Red Reishi has a substantially larger body of clinical research supporting its use, while Blue Reishi evidence remains largely preclinical, making direct efficacy comparisons unreliable at this time.

### What are the active compounds in Blue Reishi mushroom?

The primary bioactive compounds in Ganoderma sinense are beta-glucan polysaccharides, particularly beta-1,3 and beta-1,6 linked glucans, which are responsible for immunomodulatory and antitumor effects. Triterpenoids including ganoderic acids (notably ganoderic acid A, B, and C variants) contribute to anti-inflammatory, antioxidant, and cytotoxic properties observed in preclinical studies. Additionally, proteoglycans and sterols such as ergosterol have been isolated and are under investigation for secondary bioactivity.

### Can Blue Reishi help with cancer treatment?

Preclinical studies have shown that Ganoderma sinense polysaccharides can reduce tumor cell proliferation and inhibit angiogenesis via suppression of HIF-1α and VEGF pathways in murine models, but no clinical trials in human cancer patients have been conducted specifically for this species. It should not be considered a substitute for conventional cancer therapies, and its role as a complementary agent has not been established in humans. Individuals undergoing chemotherapy should consult an oncologist before use due to potential interactions with immunosuppressive protocols.

### What is anticytopenia and how does Blue Reishi address it?

Anticytopenia refers to the ability to prevent or reverse abnormally low blood cell counts, including reductions in white blood cells, red blood cells, or platelets often caused by chemotherapy or radiation. Preclinical rodent studies using cyclophosphamide-induced cytopenia models showed that Ganoderma sinense polysaccharide fractions stimulated bone marrow hematopoiesis, increasing white blood cell and platelet counts. This effect is thought to be mediated through cytokine upregulation including colony-stimulating factors, though human clinical validation is lacking.

### What is the recommended dosage for Blue Reishi supplement?

No standardized clinical dosage has been established specifically for Ganoderma sinense due to the absence of human clinical trials for this species. Dosage guidelines are often extrapolated from red reishi research, where typical studied doses range from 1.5 to 9 grams per day of dried mushroom powder or 150 to 900 mg per day of standardized extract. Product formulations vary significantly in polysaccharide concentration (commonly standardized to 10–30% beta-glucans), so consumers should verify the certificate of analysis and consult a healthcare provider for personalized guidance.

### Is Blue Reishi safe to take with prescription medications?

Blue Reishi may interact with certain medications, particularly anticoagulants, antiplatelet drugs, and immunosuppressants, due to its bioactive polysaccharides and potential immune-modulating effects. If you are taking any prescription medications, consult your healthcare provider before adding Blue Reishi supplements to avoid potential interactions. Research on specific drug interactions remains limited, making professional medical guidance essential for safe concurrent use.

### Who should avoid taking Blue Reishi supplements?

Blue Reishi should be avoided by individuals with bleeding disorders, those scheduled for surgery, and pregnant or breastfeeding women due to insufficient safety data in these populations. People with mushroom allergies or immunocompromised conditions requiring medication should consult a healthcare provider before use, as immune-stimulating effects may complicate their conditions. Additionally, those taking blood thinners or immunosuppressive medications should seek medical advice before supplementation.

### How does the strength of clinical evidence for Blue Reishi compare to other medicinal mushrooms?

Clinical evidence for Blue Reishi remains preliminary and mostly preclinical, with most studies conducted in laboratory or animal models rather than human trials. In comparison, Red Reishi has significantly more human clinical research supporting its use for sleep and immune support, making it more established in scientific literature. Blue Reishi shows promise in antitumor and antioxidant research, but these findings require translation to controlled human studies before definitive therapeutic claims can be made.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*